• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An intermolecular C–H oxidizing strategy to access highly fused carbazole skeletons from simple naphthylamines?
  Christian K. Rank,Alexander W. Jones,Tatjana Wall,Patrick Di Martino-Fumo,Sarah Schr?ck,Markus Gerhards,Frederic W. Patureau Chem. Commun., 2019,55, 13749-13752
• 3. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 4. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 5. An assay for the enzyme N-acetyl-β-d-glucosaminidase (NAGase) based on electrochemical detection using screen-printed carbon electrodes (SPCEs)
  R. M. Pemberton,J. P. Hart,T. T. Mottram Analyst, 2001,126, 1866-1871

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyrimidines Pyrrolo[2,3-d]pyrimidines

Introduction to 7H-Pyrrolo[2,3-d]pyrimidine-5-carbaldehyde (CAS No. 1060815-89-5)

7H-Pyrrolo[2,3-d]pyrimidine-5-carbaldehyde, identified by the CAS number 1060815-89-5, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology due to its structural complexity and potential biological activities. This compound belongs to the pyrrolopyrimidine class, a scaffold that is widely recognized for its role in the development of various therapeutic agents, particularly those targeting cancer and inflammatory diseases.

The molecular structure of 7H-Pyrrolo[2,3-d]pyrimidine-5-carbaldehyde features a fused ring system consisting of a pyrrole ring and a pyrimidine ring, with a formyl group (-CHO) at the 5-position. This particular arrangement of functional groups makes it a versatile intermediate in organic synthesis, enabling further derivatization to produce novel compounds with tailored biological properties. The presence of the aldehyde group not only facilitates condensation reactions but also suggests potential applications in the synthesis of Schiff bases and other functional molecules.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors for kinases and other enzymes involved in cancer progression. 7H-Pyrrolo[2,3-d]pyrimidine-5-carbaldehyde has emerged as a promising scaffold for designing such inhibitors due to its ability to mimic natural substrates and interact with target enzymes. Several studies have demonstrated its potential in inhibiting tyrosine kinases, which are overexpressed in many cancer cell lines. The aldehyde group at the 5-position serves as a reactive site for covalent bonding with key residues in the active site of these enzymes, leading to potent inhibition.

One of the most compelling aspects of 7H-Pyrrolo[2,3-d]pyrimidine-5-carbaldehyde is its role as a precursor in the synthesis of more complex derivatives. Researchers have leveraged this compound to develop novel analogs with enhanced selectivity and reduced toxicity. For instance, by introducing various substituents at different positions of the pyrrolopyrimidine core, scientists have been able to fine-tune the pharmacokinetic properties of these derivatives. This approach has led to the discovery of several lead compounds that are currently undergoing preclinical evaluation for their efficacy in treating solid tumors and hematological malignancies.

The interest in 7H-Pyrrolo[2,3-d]pyrimidine-5-carbaldehyde extends beyond oncology. Emerging evidence suggests that this compound may also have anti-inflammatory and immunomodulatory effects. In particular, derivatives of this scaffold have shown promise in modulating immune checkpoints, which are critical regulators of immune responses. By targeting these pathways, such compounds could potentially be used to treat autoimmune diseases and chronic inflammatory conditions. Additionally, preliminary studies have explored their potential in antiviral applications, highlighting the broad therapeutic scope of this molecule.

The synthesis of 7H-Pyrrolo[2,3-d]pyrimidine-5-carbaldehyde typically involves multi-step organic reactions starting from readily available precursors. Common synthetic routes include cyclization reactions followed by formylation at the 5-position. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making this compound more accessible for further research and development. The ability to produce high-purity samples is crucial for downstream applications such as crystallographic studies and enzyme binding assays.

From a computational chemistry perspective, 7H-Pyrrolo[2,3-d]pyrimidine-5-carbaldehyde has been extensively studied using molecular modeling techniques. These studies aim to understand its interactions with biological targets at an atomic level. By predicting binding affinities and identifying key interaction points, researchers can rationalize structure-activity relationships (SARs) and guide the design of next-generation analogs. Such computational approaches are integral to modern drug discovery pipelines, providing insights that would be difficult or impossible to obtain through experimental alone.

The pharmacological evaluation of 7H-Pyrrolo[2,3-d]pyrimidine-5-carbaldehyde derivatives has revealed several interesting findings. For example, certain analogs have demonstrated significant inhibitory activity against mutant forms of kinases associated with resistance to existing therapies. This underscores the importance of developing next-generation inhibitors that can overcome such resistance mechanisms. Furthermore, pharmacokinetic studies have highlighted the need for optimizing solubility and metabolic stability to enhance bioavailability and prolong systemic exposure.

In conclusion,7H-Pyrrolo[2,3-d]pyrimidine-5-carbaldehyde (CAS No. 1060815-89-5) represents a valuable scaffold for pharmaceutical innovation. Its unique structural features and reactivity make it an attractive building block for designing small-molecule inhibitors with therapeutic potential across multiple disease areas. As research continues to uncover new biological functions and synthetic strategies for this compound,7H-Pyrrolo[2,3-d]pyrimidine-5-carbaldehyde is poised to play an increasingly important role in the development of next-generation therapeutics.

• 4649-09-6(3-Formyl-7-azaindole)
• 728034-12-6(1H-Pyrrolo[2,3-b]pyridine-4-carbaldehyde)
• 1234616-77-3(7H-Pyrrolo[2,3-d]pyrimidine-5-carboxylic acid)
• 933746-87-3(1,8-naphthyridine-3-carbaldehyde)
• 454685-89-3(7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamide)
• 1190321-17-5(5-Methyl-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde)
• 1000340-48-6(3-formyl-1H-pyrrolo[2,3-b]pyridine-4-carbonitrile)
• 4894-34-2(4-methyl-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde)
• 849067-90-9(1H-Pyrrolo[2,3-b]pyridine-5-carbaldehyde)
• 1190311-90-0(7-Azaindole-3,4-dicarbaldehyde)